Optimal cutoff of polypharmacy and outcomes - reply

Comment

Danijela Gnjidic et al. J Clin Epidemiol. 2013 Apr.

. 2013 Apr;66(4):465-6.

doi: 10.1016/j.jclinepi.2012.10.007. Epub 2013 Jan 18.

No abstract available

Comment on

Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.
Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, McLachlan AJ, Cumming RG, Handelsman DJ, Le Couteur DG. Gnjidic D, et al. J Clin Epidemiol. 2012 Sep;65(9):989-95. doi: 10.1016/j.jclinepi.2012.02.018. Epub 2012 Jun 27. J Clin Epidemiol. 2012. PMID: 22742913
Optimal cutoff of polypharmacy and outcomes.
Lai SW, Liao KF. Lai SW, et al. J Clin Epidemiol. 2013 Apr;66(4):465. doi: 10.1016/j.jclinepi.2012.10.008. Epub 2013 Jan 18. J Clin Epidemiol. 2013. PMID: 23337780 No abstract available.